Amarin Corp PLC (AMRN)
0.8857
+0.01
(+0.65%)
USD |
NASDAQ |
Apr 24, 16:00
0.8798
-0.01
(-0.67%)
After-Hours: 16:16
Amarin Total Liabilities (Quarterly): 279.59M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 279.59M |
| September 30, 2023 | 285.88M |
| June 30, 2023 | 290.89M |
| March 31, 2023 | 275.40M |
| December 31, 2022 | 290.85M |
| September 30, 2022 | 320.48M |
| June 30, 2022 | 393.19M |
| March 31, 2022 | 332.60M |
| December 31, 2021 | 400.97M |
| September 30, 2021 | 393.31M |
| June 30, 2021 | 399.67M |
| March 31, 2021 | 355.64M |
| December 31, 2020 | 338.52M |
| September 30, 2020 | 352.95M |
| June 30, 2020 | 312.11M |
| March 31, 2020 | 339.89M |
| December 31, 2019 | 273.95M |
| September 30, 2019 | 271.04M |
| June 30, 2019 | 240.84M |
| March 31, 2019 | 231.37M |
| December 31, 2018 | 233.38M |
| September 30, 2018 | 263.11M |
| June 30, 2018 | 250.82M |
| March 31, 2018 | 232.37M |
| December 31, 2017 | 226.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 212.72M |
| June 30, 2017 | 208.95M |
| March 31, 2017 | 203.97M |
| December 31, 2016 | 176.06M |
| September 30, 2016 | 178.73M |
| June 30, 2016 | 312.05M |
| March 31, 2016 | 308.85M |
| December 31, 2015 | 300.78M |
| September 30, 2015 | 293.51M |
| June 30, 2015 | 286.52M |
| March 31, 2015 | 277.16M |
| December 31, 2014 | 259.56M |
| September 30, 2014 | 254.61M |
| June 30, 2014 | 255.82M |
| March 31, 2014 | 277.80M |
| December 31, 2013 | 286.33M |
| September 30, 2013 | 311.54M |
| June 30, 2013 | 309.00M |
| March 31, 2013 | 331.42M |
| December 31, 2012 | 314.85M |
| September 30, 2012 | 254.96M |
| June 30, 2012 | 265.86M |
| March 31, 2012 | 325.25M |
| December 31, 2011 | 132.34M |
| September 30, 2011 | 162.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
240.84M
Minimum
Jun 2019
400.97M
Maximum
Dec 2021
323.57M
Average
320.48M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Trinity Biotech PLC | 81.08M |
| DBV Technologies SA | 42.80M |
| Adaptimmune Therapeutics PLC | 243.10M |
| Akari Therapeutics PLC | 4.584M |
| Biodexa Pharmaceuticals Plc | 7.470M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 831.68M |
| Shareholders Equity (Quarterly) | 552.10M |
| Current Ratio | 2.796 |